No details yet except (1) Biortica will be $380k to creditors (that covers the bank over draft - was there more debt left on last report but not sure), and (2) meeting for SHs to vote soon.
I think it will be Biortica valued at an even number of millions (say $18mil) vs existing BOD valued at just <$1million.
So the offer, may
(1) Biortica pays the outstanding debt.
(2) Existing share holders keep your shares but Current shares compressed in exchange 10:1 so 177,333,333 shares becomes 17,733,333 shares (this may happen after the proposed merge too).
(3) Biortica gets 17,333,333 x 18 shares in a script for script deal (ie 319,200,000 shares)
Final result existing shareholders have 5% ish in Biortica
Just a guess.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities Report / Appendix 4C
No details yet except (1) Biortica will be $380k to creditors...
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOD (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.256M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
BOD (ASX) Chart |
Day chart unavailable
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online